Tata Chemicals (TATACHEM) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
8 Jul, 2026Executive summary
Global soda ash demand grew, led by China and India, but overall market conditions remained challenging with muted or declining demand in other regions; India is expected to continue growing.
FY25 saw higher sales volumes but lower realisation, resulting in declines in revenue, EBITDA, and PAT year-over-year.
Major capex was undertaken in India and for salt/pharma grade expansion in the UK; UK soda ash operations ceased in Feb 2025.
Net loss for FY25 stood at ₹841 crore, primarily due to exceptional items and impairment charges in the UK.
Credit ratings reaffirmed by CRISIL AA+ and Moody's Ba1.
Financial highlights
Consolidated FY25 revenue: ₹14,887 crore (↓3% YoY); EBITDA: ₹1,953 crore (↓31% YoY); PAT before exceptional items: ₹479 crore; net loss after exceptional items: ₹841 crore.
Q4FY25 revenue: ₹3,509 crore; EBITDA: ₹327 crore; PAT: -₹12 crore.
Standalone FY25 revenue: ₹4,441 crore; EBITDA: ₹818 crore; PAT: ₹524 crore.
Consolidated operating margin for FY25 was 5.58%, down from 12.11% in FY24.
Net debt increased to ₹7,072 crore in FY25, mainly due to working capital and capex.
Outlook and guidance
Medium- and long-term outlook remains positive, driven by sustainability trends (solar PV, EV growth), despite current softness and tariff uncertainties.
India and Kenya expected to continue positive momentum; U.K. to stabilize post-restructuring by Q2 FY26.
The Board recommended a final dividend of ₹11.00 per share for FY25, subject to shareholder approval.
Management is focused on cost optimization and operational efficiency amid ongoing market headwinds.
Latest events from Tata Chemicals
- India growth offset by weak global prices and UK closure; ₹1,500 crore NCD fund raise approved.TATACHEM
Q2 25/269 Jul 2026 - Soda ash oversupply and weak prices drove losses, but India and expansions support future growth.TATACHEM
Q3 25/268 Jul 2026 - Net loss of ₹1,715 crore driven by US impairment, but leverage low and dividend maintained.TATACHEM
Q4 25/264 May 2026 - Revenue and profit fell on low prices and UK closure; net debt and risks increased.TATACHEM
Q3 24/253 Feb 2026 - Sequential revenue and EBITDA growth, but year-over-year declines amid European market headwinds.TATACHEM
Q1 24/252 Feb 2026 - Q2 FY25 revenue ₹3,999 crore, net profit ₹267 crore, expansions ramping up post-rains.TATACHEM
Q2 24/2519 Jan 2026 - Q1 FY26 saw higher profit and margins despite flat demand and global oversupply.TATACHEM
Q1 25/2625 Jul 2025